TSP TruSpine Technologies Plc

22 February 2024

TruSpine Technologies plc

("TruSpine" or the "Company")

Shareholder Requisition Notice

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has received a requisition notice from a shareholder group proposing certain changes to the Board. The Company has now received advice regarding the validity of the requisition notice, which has been confirmed as invalid. The requisitioning shareholders have been informed and shareholders are advised to take no action at this time.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.